10 ms·
New Data on T Cells and the Coronavirus
- est31 6y ago> [T]his paper shows that these patients still have (17 years later!) a robust T-cell response to the original SARS coronavirus’s N protein, which extends an earlier report of such responses going out to 11 years. This new work finds that these cross-react with the new SARS CoV-2 N protein as well. This makes one think, as many have been wondering, that T-cell driven immunity is perhaps the way to reconcile the apparent paradox between (1) antibody responses that seem to be dropping week by week in convalescent patients but (2) few (if any) reliable reports of actual re-infection. That would be good news indeed.
- mycall 6y agoCould a lab theoretically take your T-cells and "upgrade" them with all kinds of immunity robustness against say 100 viruses?
- lactobacillis 6y agoThat is what vaccines do as I understand it.
- frisco 6y agoTotally. This is called "adoptive cell transfer" and it's one of the hottest areas of biotech at the moment. https://en.wikipedia.org/wiki/Adoptive_cell_transfer https://en.wikipedia.org/wiki/Adoptive_cell_transfer
- ineedasername 6y agoWow, sure it's not at "super human" immune system levels yet, but this is the type of research that feels like we're entering SciFi territory.
- _jahh 6y agoyou type into your glowing device connected nigh-instantaneously to a hefty proportion of the world.
- smsx 6y agoyes, but i’m used to that already :)
- vkou 6y agoSo, like an 1840s telegraph, but a bit better and with more spyware?
- adrianN 6y agoThis cell transfer thing is just like a vaccination, but better. And a 2020 car is just like an 1820 train, but better. And a computer is just a programmable loom, but better.
- 3pt14159 6y agoHaha, I was with you until the computer comparison. A 2020 car can go an order of magnitude faster than a 1820 train. A 2020 computer can go so much faster I can't even estimate how many orders of magnitude with certainty.
- ineedasername 6y agoYep, and I remember when I got my first kindle e-ink reader, the first one they made, and was in awe because between that and the first iphone a few months earlier, it reminded me so much of the device described in Neal Stephenson's Diamond Age. I got used to it, and the feeling went away. I had a similar feeling when I got a bluetooth headset where I just had to tap and speak and Google would answer almost any question I had, no need to even half shout "OKAY GOOGLE" for my phone to hear. I now actually feel dumber without such a headset because I can't easily get answers to random questions. So, yeah, we get used to these things. The measure of "being in the future" is less the awe we have at technological marvels and more the way they become common place and accepted.
- mromanuk 6y agoAlways wonder about the data density of this type of information: it’s possible to Store all the virus? It’s LIFO stack? What’s the limit?
- ztjio 6y agoIn tech terms? It's probably more like a bloom filter, which means eventually it can be a problem if it starts to get too many false positives.
- blueblisters 6y agoFalse positives as in it starts attacking healthy/friendly cells? That seems like a pretty big downside.
- beagle3 6y agoIt is a huge problem. It’s called “autoimmune disease”, and global prevalence is on the rise. AFAIK the hypothesis is that is a result of modern life being “too clean”, so not enough “unfriendly” variety to train on.
- layoutIfNeeded 6y agoHappens 1 in 100k people every year. It's called Guillain-Barré syndrome [1]. After an infection your immune system gets confused and starts attacking your peripheral nerves. [1] https://en.wikipedia.org/wiki/Guillain–Barré_syndrome https://en.wikipedia.org/wiki/Guillain–Barré_syndrome
- shawnz 6y agoThat's just one of many possible autoimmune diseases.
- layoutIfNeeded 6y agoYes, of course there are tons of autoimmune diseases (from mild allergies, to lupus, multiple sclerosis, and sympathetic ophthalmia), but Guillain-Barré syndrome is an autoimmune disease that's known to occur after otherwise banal infections or even vaccine shots. That's why I considered it more relevant to the OP than other autoimmune diseases.
- raducu 6y agoI'm not familiar with what T cells do, I thought they did not have a single target, unlike antibodies -- wouldn't transplanting T cells mean they would immediately attack the patients cells, as they are detected as foreign?
- twic 6y agoT cells have a single target, like antibodies. The target is a peptide, a fragment of a protein 8-11 residues long. That peptide could show up in several target proteins, but usually (?) is unique to one protein. This is a bit of an oversimplification. Firstly, the peptide is 8-11 residues for cytotoxic, aka killer, T cells which i think is what we're talking about here. It's 13-17 residues for for helper T cells. Secondly, there are varieties of T cells which don't have a single target, like invariant natural killer T cells, but those are pretty obscure, and not what people are talking about when they just say "T cells".
- jmrko 6y agoI don't think it is clear at this point that there are unexpected antibody titer drops in comparison to other viruses, Florian Krammer's work looks solid to me: https://threadreaderapp.com/thread/1285618977654407169.html https://threadreaderapp.com/thread/1285618977654407169.html and original preprint: https://www.medrxiv.org/content/10.1101/2020.07.14.20151126v1 https://www.medrxiv.org/content/10.1101/2020.07.14.20151126v...
- baxtr 6y agoIt’s at least not perfectly clear yet. I know some people who tested PCR positive and had negative AB test outcomes. Kramer writes in his pre-print that you’ve linked: >Of note, our observations are in contrast to a recent report by Long et al. that found waning titers 8 weeks post 138 virus infection as compared to acute responses (19). Especially in asymptomatic cases, antibody 139 responses disappeared after 8 weeks in 40% of individuals in the Long et al. study. However, the 140 antibodies measured in their paper were targeting the NP plus a single linear spike epitope. Much 141 more in agreement with our data, the same paper also reports relatively stable (slightly declining) 142 neutralizing antibody titers. The stability of the antibody response over time might therefore also 143 depend on the target antigen. The titers we measure here do correlate with neutralization as 144 discussed above.
- rossdavidh 6y ago"The paper speculated that this might be due to cross-reactivity with proteins from the “common cold” coronaviruses”, and raised the possibility that there might be a part of the population that has at least some existing protection against the current pandemic." ...this might explain why different parts of the world (e.g. east Asia, including Australia and New Zealand, vs. western Europe) have vastly different outcomes that don't seem to correlate well to genetics, culture, or policy. If a "common cold" coronavirus hit east Asia in the past, but never made it to western Europe, it could explain the different impact.
- deleted 6y ago[deleted]
- jhpriestley 6y agoThe virus spread quite well in Wuhan and the South Korean church though. Why do you dismiss the significant policy differences as a sufficient explanation?
- adventured 6y agoIt fails to explain why countries like Vietnam, the Philippines and Indonesia have so few deaths. There are 470 million people between those three Asian nations, and fewer deaths than in Canada (which has done a very sound job against the virus). Indonesia has as many deaths as Sweden, with ~26 times the population. The Philippines has 1,846 deaths vs Brazil which has 82,771. Bangladesh has 2,751 deaths, 30% of what Germany has, despite Bangladesh having nearly twice as many people. The Germans responded in extraordinary fashion to the virus. Bangladesh has so few deaths because their response was vastly superior, better funded, better organized, technologically superior in its testing and tracing? Comeon. The Philippines had an amazing response to the virus compared to Germany or Canada or Brazil or Switzerland? No way. There's definitely more going on there, including an impact from the different climates. It's entirely reasonable that some parts of Asia could have greater immune protection due to past virus exposures.
- pavs 6y ago
- xoxoy 6y agocurious who wins the vaccine race. my understanding is the RNA vaccines being researched by Moderna and Inovio don’t stimulate T-cell development, in which case they seem like poor candidates compared to the adenovirus candidates like the Oxford one that do.
- dnautics 6y agoso mRNA vaccination is an offshoot towards technology which was created about a decade and a half ago to make more efficient monoclonal antibodies for the lab. The process is to extract B-cells from a challenged organism (almost always mouse) and then fuse them as 'hybridomas' with immortal cancer cells, select single cell clumps that show an immune response out of multi-well plates, and then use those immortalized cells to make that one antibody forever. So indeed the mRNA vaccines come from technology that is highly optimized to elicit a B-cell response. (Not to say that it doesn't stimulate T-cells, but I wouldn't be surprised if it didn't).
- rotexo 6y agoWait I’m a little confused. It seems like injecting people with an mRNA, which their cells then translate into an antigen that provokes an immune response, is a very different technology from monoclonal antibodies. They are both related to the immune system, but mRNA vaccines are at least partially about stimulating polyclonal antibody production, as opposed to monoclonal antibodies. Can you articulate why you think mRNA vaccines were derived from monoclonal antibody work?
- dnautics 6y agoI just remember talks (I was at a cutting-edge immunology research center, The Scripps Research Institute in San Diego) about using mRNA vaccination in the 2007-2009 era to make monoclonal antibodies. Oddly, I can't find any publications from that era on it (but I can find a few papers from 2017-2019 using that exact methodology), so it appears that either i was mistaken, or it quietly pivoted to human vaccination as a target. It's really not possible for me to be mistaken about the timeframe, though, since I have been out of biology since 2015.
- walterbell 6y agoIn addition to these promising results, note that southern U.S. states have been dealing with a dust storm from the Saharan desert, which increased air pollution in late June, https://www.yaleclimateconnections.org/2020/06/saharan-dust-storm-expected-to-cause-dangerous-air-pollution-in-u-s-this-week/ https://www.yaleclimateconnections.org/2020/06/saharan-dust-... > The dust cloud is bringing dangerously high levels of fine particulate pollution (PM2.5, particles less than 2.5 microns or 0.0001 inch in diameter) and PM10 (particles less than 10 microns in diameter). Air pollution aggravates COVID-19 symptoms, leading to expected increases in hospital admissions from the disease in regions where dust concentrations spike. We don't yet have good data to correct for the health impact of breathing in these minute particles from Africa, especially for those with pre-existing conditions.
- crowbahr 6y agoWhile this is an interesting datum, I don't see how it's pertinent to the comments section.
- nickthemagicman 6y agoI'm in the south. Not a sign of dust here. Even my dark colored car is clean.
- walterbell 6y agoIt was several weeks ago. Some photos here, https://www.msn.com/en-us/weather/topstories/the-sahara-dust-storm-has-reached-the-us-mainland-heres-what-it-looks-like/ar-BB160EHk https://www.msn.com/en-us/weather/topstories/the-sahara-dust...
- nickthemagicman 6y agoIn New Orleans saw nary hide nor hair of the dust. Maybe it's coastal areas only?
- andrewseanryan 6y agoIf there is a nearly harmless coronavirus going around, whether it is a common cold or previously unidentified virus (as the article suggests), that provides partial immunity to COVID, what is stopping us from purposefully infecting people with a less harmful illness to protect from COVID? Isn’t this how the first idea of vaccines came about with Cowpox and smallpox?
- _jahh 6y agomodern medical ethics. lack of efficiency is a trade off made to protect agency.
- adrianmonk 6y agoBut the pandemic takes away a different form of agency, right? So it's not extremely clear cut ethically.
- _jahh 6y agoi'm not saying "modern medical ethics" is a good thing in this case (though I think some line is obviously essential to protect the rights of the individual in the face of abuse to cure the many) but that the formal and informal accords of the medical community that constitute that system of ethics is the reason no one (except maybe an authoritarian regime with no concern for individual liberties cough xinjiang) is talking about infecting healthy people to test vaccines or build up herd immunity. this is independent of the multitude of evidence that this is bad for non-hospitalized people too https://www.medscape.com/viewarticle/934851 https://www.medscape.com/viewarticle/934851 https://news.berkeley.edu/2020/07/08/from-lung-scarring-to-heart-damage-covid-19-may-leave-lingering-marks/ https://news.berkeley.edu/2020/07/08/from-lung-scarring-to-h...
- deleted 6y ago[deleted]
- doliveira 6y agoIsolating this virus variant, to boot
- LetThereBeNick 6y agoI wonder how long it will take for “B cells” to become a buzzword.
- iworkfromhome 6y agoIs the core problem in the T-Cell? What if handling the problem is more focused on T-cell handling solutions?
- dalore 6y agoIt's not new, it's more evidence: At the end of May, however, an immunological study by the University of Zurich was published, which for the first time showed that the usual antibody tests that measure antibodies in the blood (IgG and IgM) can detect at most about one fifth of all coronavirus infections. https://www.biorxiv.org/content/10.1101/2020.05.21.108308v1 https://www.biorxiv.org/content/10.1101/2020.05.21.108308v1 At the same time, the Swiss study may explain why children usually develop no symptoms (due to frequent contact with previous corona cold viruses), and why even hotspots such as New York City found an antibody prevalence (IgG/IgM) of at most 20% – as this already corresponds to herd immunity. The Swiss study has in the meantime been confirmed by several more studies: A Swedish study showed that people with mild or asymptomatic disease often neutralized the virus with T-cells without the need to produce antibodies. Overall, T-cell immunity was about twice as common as antibody immunity. https://news.ki.se/immunity-to-covid-19-is-probably-higher-than-tests-have-shown https://news.ki.se/immunity-to-covid-19-is-probably-higher-t... A large Spanish antibody study published in Lancet showed that less than 20% of symptomatic people and about 2% of asymptomatic people had IgG antibodies. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31483-5/fulltext https://www.thelancet.com/journals/lancet/article/PIIS0140-6... A German study (preprint) showed that 81% of the people who had not yet had contact with the new corona virus already had cross-reactive T-cells and thus a certain background immunity (due to contact with previous corona cold viruses). https://www.researchsquare.com/article/rs-35331/v1 https://www.researchsquare.com/article/rs-35331/v1 A Chinese study in the journal Nature showed that in 40% of asymptomatic persons and in 12.9% of symptomatic persons no IgG antibodies are detectable after the recovery phase. https://www.nature.com/articles/s41591-020-0965-6 https://www.nature.com/articles/s41591-020-0965-6 Another Chinese study with almost 25,000 clinic employees in Wuhan showed that at most one fifth of the presumably infected employees had IgG antibodies (press article). https://www.medrxiv.org/content/10.1101/2020.06.13.20130252v1 https://www.medrxiv.org/content/10.1101/2020.06.13.20130252v... A small French study (preprint) showed that six of eight infected family members of Covid patients developed a temporary T-cell immunity without antibodies. https://www.medrxiv.org/content/10.1101/2020.06.21.20132449v1 https://www.medrxiv.org/content/10.1101/2020.06.21.20132449v...
- jhpriestley 6y ago